EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Evolving Landscape of Gout in the Female: A Narrative Review

Jennifer Lee, Nicholas Sumpter, Tony R Merriman iD, Ru Liu-Bryan iD, Robert Terkeltaub iD

Gout, Urate, and Crystal Deposition Disease · 30.12.2023 · 2 (1) · 1-16

DOI: 10.3390/gucdd2010001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gout, Urate, and Crystal Deposition Disease, online erschienen am 30.12.2023. Verfasst von Jennifer Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Rheumatology, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 065…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIAMS NIH HHS, VA Research Service.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gout is at least three times more prevalent in males than in females. However, concurrent with rising total gout prevalence, complex factors, including comorbidities, diet, lifestyle, and aging, have promoted higher gout prevalence in females. This narrative review focuses on summarizing recent developments in the landscape of gout in females and the mechanisms involved. New knowledge on sex hormone effects on both urate-excreting and urate-reabsorbing transporters and higher hypertension and chronic kidney disease prevalence in females compared to males may help explain why gout incidence rises robustly after menopause in females, to approach that in males. Racial and ethnic factors, risk profiles based on heritable genetic polymorphisms of urate transporters, diet, body mass index, and lifestyle factors differ according to sex. In addition, sex differences in clinical phenotypes, outcomes of gout, and non-gout illnesses include more frequent comorbidities, more pain and disability during gout flares, different perceptions of disease burden, and more frequent severe cutaneous hypersensitivity reaction to allopurinol in females. Collectively, such findings support the potential clinical benefits of tailoring gout and hyperuricemia treatment according to sex.

Schlagwörter

Stichwörter der Autor:innen

ABCG2COVID-19SLC2A9alcoholchronic kidney diseasefructosegouthypertensionhyperuricemiaurate transporter

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Rheumatology, Seoul St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
  • Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Department of Microbiology and Immunology, University of Otago, Dunedin 9054, New Zealand.
  • VA San Diego Healthcare System, San Diego, CA 92161, USA.
  • Division of Rheumatology, Autoimmunity and Inflammation, Department of Medicine, University of California San Diego School of Medicine, La Jolla, CA 92093, USA.

ORCID-Profile: Tony R Merriman, Ru Liu-Bryan, Robert Terkeltaub

Förderung

  • BLRD VA
  • NIAMS NIH HHS
  • VA Research Service
  • Rheumatology Research Foundation Innovation Research Award, and NIH

Zitieren

APA

Lee, J., Sumpter, N., Merriman, T. R., Liu-Bryan, R., & Terkeltaub, R. (2023). The Evolving Landscape of Gout in the Female: A Narrative Review. Gout, Urate, and Crystal Deposition Disease, 2(1), 1-16. https://doi.org/10.3390/gucdd2010001

Vancouver

Lee J, Sumpter N, Merriman TR, Liu-Bryan R, Terkeltaub R. The Evolving Landscape of Gout in the Female: A Narrative Review. Gout, Urate, and Crystal Deposition Disease. 2023;2(1):1-16. doi:10.3390/gucdd2010001

BibTeX
@article{Lee2023,
  author = {Lee, Jennifer and Sumpter, Nicholas and Merriman, Tony R and Liu-Bryan, Ru and Terkeltaub, Robert},
  title = {The Evolving Landscape of Gout in the Female: A Narrative Review},
  journal = {Gout, Urate, and Crystal Deposition Disease},
  year = {2023},
  volume = {2},
  number = {1},
  pages = {1--16},
  doi = {10.3390/gucdd2010001}
}
Kostenlos starten →